Evidence map›Paper›PMID 41429618›Full record

ArticleNan fang yi ke da xue xue bao = Journal of Southern Medical University2025

[

Xinyue Sun, Kuanyu Wang, Gang Wang, Qingquan Dai, Jing Chen, Xiangding Kong, Jia Luan

Abstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xinyue SunDepartment of Surgery II, The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin 150040, China.
Kuanyu WangDepartment of Surgery II, The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin 150040, China.
Gang WangDepartment of Surgery II, The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin 150040, China.
Qingquan DaiDepartment of Surgery II, The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin 150040, China.
Jing ChenDepartment of Surgery II, The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin 150040, China.
Xiangding KongDepartment of Surgery II, The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin 150040, China.
Jia LuanDepartment of Surgery II, The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin 150040, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo explore the therapeutic mechanism of

methodsNinety CRF patients with breast cancer and

resultsThe patients receiving FZXY Granules treatment showed significantly improved PFS, KPS, and TCM syndrome scores compared with the baseline levels and those in the control group (

conclusionsFZXY Granules alleviate CRF and improve TCM symptoms and quality of life of breast cancer patients during chemotherapy possibly by suppressing skeletal muscle cell apoptosis via regulating the AKT1/BAD/BCL-2 pathway and reducing IL-6 and IL-1β levels.

Indexed as

Breast NeoplasmsDrugs, Chinese HerbalFatigueProto-Oncogene Proteins c-aktAnimalsApoptosisbcl-Associated Death ProteinFemaleHumansMedicine, Chinese TraditionalMiceMolecular Docking SimulationProto-Oncogene Proteins c-bcl-2Signal TransductionAKT1 protein, humanbcl-Associated Death ProteinDrugs, Chinese HerbalProto-Oncogene Proteins c-aktProto-Oncogene Proteins c-bcl-2AKT1/BAD/BCL-2 signaling pathwaybreast cancercancer-related fatigueFuzheng Xiaoyan Granulesnetwork pharmacology

Identifiers

PMID41429618
PMCPMC12722123

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.